Characteristic | Number of patients (%) |
---|---|
Median age at diagnosis | 52.9 years (range: 26–82) |
Sex | |
Male | 86/172 (50) |
Female | 86/172 (50) |
Clinical stage at diagnosis | |
I | 3/172 (2) |
II | 57/172 (33) |
III | 26/172 (15) |
IV | 86/172 (50) |
Histological grade | |
Well differentiated | 0/172 (0) |
Moderately differentiated | 96/172 (56) |
Poorly differentiated | 76/172 (44) |
Race/ethnicity | |
White | 150/172 (87) |
Hispanic | 7/172 (4) |
Black | 12/172 (7) |
Asian | 3/172 (2) |
Presence of signet ring cells | 42/172 (24) |
Presence of goblet cells | 13/172 (8) |
Presence of metastatic diseasea | 127/172 (74) |
Sites of metastatic disease | |
Peritoneal only | 69/127 (54) |
Extraperitoneal only | 13/127 (10) |
Peritoneal + extraperitoneal | 45/127 (35) |
CRS for metastatic disease | 31/127 (24) |
Complete (CC-0/1) | 18/31 (58) |
Incomplete (≥ CC-2) | 13/31 (42) |